BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Piratvisuth T, Han GR, Pol S, Dong Y, Trylesinski A. Comprehensive review of telbivudine in pregnant women with chronic hepatitis B. World J Hepatol 2016; 8(9): 452-460 [PMID: 27028961 DOI: 10.4254/wjh.v8.i9.452]
URL: https://www.wjgnet.com/1948-5182/full/v8/i9/452.htm
Number Citing Articles
1
Qingqing Yang, Zhaohui Zhong, Yalan Yang, Yang Ma, Kecelia T. Flomo. Efficacy and Safety of Tenofovir in the Prevention of Perinatal Transmission of Hepatitis B, a Meta-AnalysisGastroenterología y Hepatología 2020; 43(10): 640 doi: 10.1016/j.gastrohep.2020.03.015
2
Mark R. Schleiss, Ketzela J. Marsh. Avery's Diseases of the Newborn2018; : 482 doi: 10.1016/B978-0-323-40139-5.00037-1
3
Li-fen Han, Jian-ming Zheng, Li-qing Zheng, Hai-bing Gao, Li-xia Chen, Qing-ling Xu, Yi-hong Chai, Xin Zhang, Chen Pan, Lv-feng Yao. Telbivudine can safely reduce mother-to-child transmission in chronic hepatitis B women after 12 weeks of gestationBMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4250-6
4
Xiaojun Sun, Chengwei Wang, Bian Wang, Xiuzhen Yang, Hongtao Xu, Meilong Shen, Kuichun Zhu, Susan Cu-Uvin. Efficacy of Nucleotide/Nucleoside Analogues and Hepatitis B Immunoglobulin Therapy in Blocking Mother-to-Child Transmission of Hepatitis B in an Eastern Chinese GroupInfectious Diseases in Obstetrics and Gynecology 2020; 2020: 1 doi: 10.1155/2020/4305950
5
Er-Mei Li, Li-Xin Xiao, Zhen Xu, Zhi-Shuo Mo, Jia-Qian Li, Yong-Yu Mei, Chao-Shuang Lin. Factors associated with non-compliance with breastfeeding recommendation: a retrospective survey in hepatitis B virus-infected mothers who had taken Nucleos(t)ide analogs during pregnancyBMC Pregnancy and Childbirth 2021; 21(1) doi: 10.1186/s12884-021-04020-z
6
Wei Yi, Xiuzhen Cao, Zhan Zeng, Weihua Cao, Ying Zhang, Fangfang Sun, Ying Wang, Gang Wan, Minghui Li, Yao Xie. Developmental consequences of children born from mothers with telbivudine treatment during late pregnancy: A prospective study with 3-year follow-upVirulence 2021; 12(1): 1527 doi: 10.1080/21505594.2021.1936769
7
Jia‐Horng Kao, Tarik Asselah, Xiao‐Guang Dou, Kamal Hamed. Telbivudine therapy for chronic hepatitis B: A journey to identify super‐responders and to optimize treatment using the roadmap modelJournal of Gastroenterology and Hepatology 2017; 32(1): 73 doi: 10.1111/jgh.13512
8
Jinfeng Liu, Jing Wang, Taotao Yan, Dan Du, Caijing Qi, Furong Cao, Naijuan Yao, Yuan Yang, Yingli He, Zhen Tian, Danfeng Ren, Li Zhu, Tianyan Chen, Yingren Zhao. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real‐life practiceJournal of Viral Hepatitis 2019; 26(10): 1170 doi: 10.1111/jvh.13156
9
J. Liu, T. Chen, Y. Zhao. Telbivudine therapy for gravidas with chronic hepatitis B infection and patients at risk of renal impairmentJournal of Viral Hepatitis 2017; 24(S1): 6 doi: 10.1111/jvh.12787
10
Dost Sarpel, Tatyana Kushner, Danielle Carter, Tsipora Huisman, Sophia Chiu, Douglas Dieterich. Mother-to-child transmission of hepatitis B and C virus: review of the epidemiology and current treatment optionsFuture Virology 2018; 13(1): 43 doi: 10.2217/fvl-2017-0069
11
Qingqing Yang, Zhaohui Zhong, Yalan Yang, Yang Ma, Kecelia T. Flomo. Efficacy and Safety of Tenofovir in the Prevention of Perinatal Transmission of Hepatitis B, a Meta-AnalysisGastroenterología y Hepatología (English Edition) 2020; 43(10): 640 doi: 10.1016/j.gastre.2020.03.012